A phase II trial of gefitinib in patients with non‐metastatic hormone‐refractory prostate cancer
- Eric J. Small
- , Joseph Fontana
- , Nizar Tannir
- , Robert S. DiPaola
- , George Wilding
- , Mark Rubin
- , Renee Bailey Iacona
- , Fairooz F. Kabbinavar
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.